Many studies in the literature have clearly shown the increase in creatine kinase-myocardial subfraction (CK-MB) levels and changes in electrocardiography (ECG) after stroke. However, the studies on cardiac troponin T (cTnT) which is more sensitive and specific to myocardium after stroke are relatively scarce. Moreover, its associations with volume of stroke lesions and type of stroke have not been investigated thoroughly. Thus, the aims of this study were to investigate a predictive value of cTnT in assessing myocardial injury and cardiac dysfunction in different types of stroke (hemorrhagic or ischemic stroke) and its relationship with stroke size and volume. This study included 62 patients (30 males and 32 females) with acute stroke confirmed by computed tomography (CT). Blood samples were obtained within 24 hours of stroke onset to measure the serum levels of creatin kinase (CK), CK-MB, lactate dehydrogenate (LDH), and cTnT. ECG and echocardiography were performed to assess myocardial function and left ventricular ejection fraction (LVEF). Of all patients included in the study, 20 patients (32%) demonstrated elevations in cTnT, while 28 patients (45%) had increased CK-MB levels. Serum levels of cTnT were positively correlated with stroke volume (r = 0.65, p < 0.0001), while inversely correlated with LVEF (r = −0.53, p < 0001). Serum levels of both CK-MB and cTnT were higher in patients with hemorrhagic stroke than those with ischemic stroke but this difference was not significant (p > 0.05). As a conclusion, cTnT has a higher specificity and sensitivity in detecting myocardial injury after stroke of both ischemic and hemorrhagic origins. Measurement of the serum levels of cTnT is of clinical importance in evaluating myocardial injury and provides a useful aid in estimating the volume of stroke lesions. cardiac troponin T; creatine kinase-MB; stroke; myocardial injury; stroke volume
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The determination and urgent treatment of complications of stroke would prominently decrease morbidity and mortality due to stroke (Rao et al. 1998) . The mortality during the first days after stroke is generally due to brain damage, whereas in the following weeks deaths are due to stroke complications. This important finding presents the significance of early recognition and intervention to stroke and its complications.
Many studies in the literature clearly depicted the increase in CK-MB levels and changes in ECG after stroke (Norris et al. 1979; Rudehill et al. 1982; Brouwers et al. 1989; Kuroiwa et al. 1995) . However the studies searching for cTnT which is more sensitive and specific to myocardium after stroke, is relatively scarce (James et al. 2000; Parekh et al. 2000) . Moreover, to our knowledge, its associations with stroke volume and type of stroke have not been investigated thoroughly.
Therefore, the aims of this study were to investigate a predictive value of cTnT in assessing myocardial injury and cardiac dysfunction in different types of stroke (hemorrhagic or ischemic stroke) and its relationship with volume of strole lesions.
MATERIAL AND METHODS
The patients with acute stroke (either ischemic or hemorrhagic in origin) as confirmed by computed tomography (CT) scan of the brain who were referred to and hospitalized in Neurology Intensive Care Unit of Dicle University, Diyarbakir, Turkey, between November 2001 and October 2002 within 24 hours of onset of their symptoms were included in this study. The patients with a history of known coronary artery disease, heart failure, major cardiac surgery, or chronic atrial fibrillation and renal impairment were excluded from the study as it may confound our findings. Among 74 consecutive patients who were qualified to be included in the study, 62 of them were included in the study, as others met the exclusion criteria. This study conducted on human subjects has been approved by Dicle University Faculty of Medicine Ethical Committee. All patients or first degree relatives were informed about the study and their consent have been received before the initiation of the study.
world (Goldstein 1978; James et al. 2000) .
It's now common knowledge that either ischemic or hemorrhagic cerebrovascular disorders have a negative effect on cardiac functions (Norris et al. 1979; Ay et al. 2002; Butcher and Parsons 2002) . Cardiac abnormalities, as judged by release of cardiac enzymes, changes in electrocardiography (ECG), or clinical or echocardiographic evidence of left ventricular dysfunction usually develop just after intracerebral disorders (i.e., stroke, subarachnoid hemorrhage) (Bhagat et al. 1997; James et al. 2000) . The exact underlying pathophysiological mechanism of this myocardial dysfunction could not be determined in many cases. However excessive catecholamine discharge may be responsible for myocardial dysfunction in many cases (White et al. 1995) .
In myocardial damage, serum levels of different cardiac enzymes and proteins (i.e., creatine kinase-myocardial subfraction [CK-MB] and cardiac troponin T [cTnT]) increase dramatically (Norris et al. 1979) . Although CK-MB is a commonly used marker of myocardial necrosis, it may also be released as a result of damage to non-cardiac muscle which decreases its specificity (Norris et al. 1979) . Furthermore some patients may develop clinically important myocardial dysfunction due to sublethal injury that does not result in CK-MB release. The major advantage of cTnT over CK-MB is its ability to detect even minimal myocardial cell damage with high sensitivity and specificity that is undetectable by conventional enzyme methods (Mair 1997; Rao et al. 1998; Jurlander et al. 2000; Lindahl et al. 2001) .
CTnT has a predictive value for prognosis, along with its high specificity and sensitivity to myocardial injury (Lindahl et al. 1996) . In acute coronary syndromes, there is a close relation between high troponin levels and mortality (Kolin and Norris 1984; Bhagat et al. 1997) . Other noncoronary related disorders resulting in elevation of cTnT are myocarditis, acute pulmonary edema, septic shock, cardiotoxic medication, cardioversion, ablation, percutaneous transcoronary angiography (PTCA) and renal insufficiency. Stroke, which also results in myocardial injury, causes elevation in cTnT levels (Mair 1997; James et al. In addition to general systematic clinical assessment and physical examination of patients, detailed cardiac and neurological evaluation have been conducted by specialists for all cases. All patients underwent twelve-lead ECG, echocardiography and brain CT scan. The serum levels of CK, CK-MB, lactate dehydrogenase (LDH) and cTnT were also measured in all cases.
ECG was performed on the first, second, third and fifth days after stroke and echocardiography on the third day. All abnormalities observed in ECG (i.e., S-T changes and arrhythmias) were recorded. The significant ST-T segment changes were defined if patient fulfills at least one of the following criteria; 1 mm elevation or depression of S-T segment at least in two derivations; T-wave inversion or flattening. The criteria to diagnose myocardial dysfunction in echocardiography were evidence of segmental wall-motion abnormalities or a globally reduced left ventricular ejection fraction (LVEF < 50%). Echocardiography was performed on VingMed CFM 800 device with 3.5 MHz and 2.5 MHz transducers, while the patient were positioned lying on their left side. The analysis was performed off-line by a single experienced physician blinded to the patients' symptom status and cTnT levels. The echocardiographic images were taken from parasternal long and short axis and apical four-chamber views, as defined by the American Society of Echocardiography (Schiller et al. 1989 ). Left ventricular dimension was calculated from parasternal long axis M-mode measurements; whereas LVEF was calculated via modified Simpson method from four chamber views.
Blood samples were collected daily for 7 days after stroke to measure the biochemical indicators of myocardial injury (i.e., CK, CK-MB, LDH and cTnT). The mean values and peak values have been calculated for further statistical analysis. An immunological assay, Trop T assay (Roche Diagnostics, Mannheim, Germany), has been used to measure serum levels of cTnT quantitatively. Additionally the cTnT cut off value ( 0.1 ng/ml) has been used in this study to make further comparisons.
The volume and the diameter of stroke lesions (infarct or hematoma) were also calculated by brain CT scan, taken at the first and third day. In the previous studies (Olsen et al. 1985; Skriver et al. 1990 ), the subjects were classified into three different groups based on the diameter of stroke lesions (> 3 cm, severe; 1.5 -3 cm, moderate; < 1.5 cm mild lacunar). In the current study, we used a cutoff point of 3 cm for diameter of stroke lesions by combining mild and moderate cases into < 3 cm group to ease further statistical comparisons. Brain CT scan were performed on Toshiba X vision (Toshiba, Tokyo).
Statistical analysis
Categorical variables were compared by the Chisquare test; continuous variables were compared by student t-test. For the correlations between cTnT and other parameters, Pearson correlation test was used. P value was set at 0.05 for statistical significance. Analyses were performed with SPSS for Windows, version 11.0.
RESULTS
Sixty-two patients were included into this study; 36 of them (58%) had ischemic thromboembolism and 26 (42%) had intracranial hemorrhage as the etiology of stroke (Table 1) . Among all patients, 20 (32%) patients demonstrated elevations of mean cTnT levels. In 28 patients (45%) the levels of CK-MB were elevated in two or more different measurements. Four of the 20 patients with elevated cTnT had normal CK-MB level, whereas 3 patients with an elevated CK-MB had normal cTnT level. The clinical and demographic characteristics of the study population are illustrated in Table 1 .
The patients with ST-T abnormalities (n = 26) had higher cTnT values compared to those without ST-T abnormalities (0.23 ± 0.24 μ g/liter and 0.05 ± 0.1 μ g/liter respectively; p < 0.001). On the other hand, there was no significant difference between patients with elevated and normal CK-MB levels in regards to ST-T abnormalities (p > 0.05). ST-T changes have been observed in 90% of patients with elevated serum levels of cTnT whereas this figure was 50% in patients with elevated serum levels of CK-MB (Table 2  and Table 3 ). In cases with elevated cTnT levels, ischemic ST-T changes were significantly higher than patients with normal cTnT levels (Table 2; p < 0.0001). This significance has not been observed in between patients with higher and normal CK-MB levels (Table 3) .
LVEF, an indicator for LV systolic function, was significantly lower in patients with elevated cTnT than in patients with normal level of cTnT (Table 2 ; p < 0.001). Though the LVEF was lower in cases with elevated CK-MB levels than cases with normal CK-MB levels (58.3% vs 60.3% respectively) the difference did not reach to significance level (Table 3 ; p > 0.05). Volume of stroke lesion was significantly higher both in patients with elevated cTnT and patients with elevated CK-MB (Tables 2 and 3 ). The comparison of some clinical and laboratory findings between patients with elevated cTnT or elevated CK-MB and patients with normal levels of cTnT or CK-MB are listed in Tables 2 and 3 , respectively.
Abnormal ECG findings were detected in 43 (63%) patients. The most frequent abnormalities were ST-T changes (26/43; 42%), followed by prolonged QT intervals (11/43; 18%), and supraventricular arrhythmias (9/43; 15%). In this study, the sensitivity and specificity of cTnT to predict myocardial dysfunction -as defined by echocardiography-were 100% and 93%, respectively. On the other hand, the sensitivity and specificity of CK-MB to predict myocardial dysfunction was lower than the values estimated for cTnT (69% and 91% respectively). CK-MB and cTnT reached their peak values on the first day after stroke. CK-MB levels returned to its normal range on the fifth day after stroke, whereas cTnT value did not show any difference till fifth day.
There was a significant negative correlation between cTnT level and LVEF (r = −0.53, p < 0.0001) and a positive correlation between cTnT levels and stroke volume (r = 0.65, p < 0.0001) (Fig. 1) . Besides a significant inverse correlation between LVEF and stroke volume has also been detected (r = −0.58, p < 0.0001) (Fig. 2) . Assessment of patients based on a cut off value of 3 cm for diameter of stroke lesion (Table  4) showed that mean levels of CK-MB and cTnT were significantly higher in patients with larger lesions ( > 3 cm) (p < 0.05; Table 4 ). Besides, LVEF was significantly decreased in patients whose diameter of stroke lesion was > 3 cm (Table  4 ; p < 0.03).
The comparison of patients based on their etiology of stroke (i.e., hemorrhagic or ischemic stroke) revealed that ischemic stroke patients were older in age (65.9 vs 52.9 years; p < 0.05) whereas hemorrhagic stroke patients had significantly higher systolic and diastolic blood pressure (p < 0.05) and volume of stroke lesion (p < 0.05). No significant difference were found in between these groups with regards to biochemical (glucose, cTnT, CK-MB levels), echocardiographic (LVEF) and electrocardiography (ST-T abnormalities) data examined (p > 0.05) ( Table 5) . 
DISCUSSION
In the current study 32% of the stroke patients (n = 20) had elevated serum levels of cTnT whereas 45% of patients (n = 28) had elevated serum levels of CK-MB. While the rate for cTnT was in line with the data of Ay et al.'s (2002) study (30 out of 181 patients; 34%), it was still higher then the figure reported by another study (17%) (James et al. 2000) . Parekh et al. (2000) examined 39 patients with confirmed aneurysmal subarachnoidal hemorrhage and found that 8 (20%) patients had elevated cTnT. In the same study (Parekh et al. 2000) , only 5 (13%) patients had elevated CK-MB in contrast to our findings.
It is already known that an acute stroke may be followed by electrocardiographic changes, cardiac arrhythmias, and a rise in CK-MB concentration (James et al. 2000) . CTnT concentration is also known to be more sensitive and specific marker for cardiac injury than CK-MB concentrations. Several studies suggested that cTnT could be a valuable marker for the evidence of myocardial injury in ischemic stroke patients (Ay et al. 2002) . We have searched for the evidence if cTnT could also be used as a reliable marker for myocardial injury in hemorrhagic stroke patients as well and if there exist any difference between patients with different stroke etiology (i.e., ischemic or hemorrhagic). In the present study serum concentrations of both CK-MB and cTnT were higher in patients with hemorrhagic stroke than those with ischemic stroke but this difference was not significant (p > 0.05, Table 5 ). This result suggests that cTnT could also be used as an indicator for myocardial injury in homographic stroke as in ischemic stroke patients.
One of the novel findings of this study was the significant correlation between cTnT levels and volume of stroke lesion as demonstrated via CT scan. Serum levels of cTnT was positively correlated with stroke volume in the present study (r = 0.65, p < 0.0001). This is an important finding which is complementary to the results of re- cent study noting the usefulness of cTnT measurement as a noninvasive estimate of myocardial infarct size and for the assessment of LV function routine clinical setting (Panteghini et al. 2002) . In our patients, the increase in the stroke volume was most probably a consequence of increased myocardial injury, which could be clearly observed with the increase in serum levels of cTnT and CK-MB and reduction in LVEF.
In the present study, echocardiography of all patients with high cTnT reveals segmental wallmotion abnormalities or reduced LVEF. However, abnormal echocardiographies were seen in only some of our patients with elevated CK-MB. The decrease in LVEF was more prominent in patients with elevated cTnT than in patients with elevated CK-MB. Additionally we have also noted a significantly inverse correlation between serum levels of cTnT and LVEF (Fig. 2) . These data were in line with the previous findings in literature reporting significantly inverse correlation between LVEF and cTnT (Kuroiwa et al. 1995; Bhagat et al. 1997; Panteghini et al. 2002) .
In our study, 26 (42%) patients demonstrated ST-T abnormalities in ECG. cTnT value were higher in these patients with ECG abnormalities. In this group of patients, increases in levels of CK-MB were not statistically significant. Although majority of the earlier studies marked the determined ST-T abnormalities as non-specific in these patients (Rudehill et al. 1982) , the correlation between elevated cTnT levels and echocardiographic abnormalities lead us to think that these ST-T abnormalities were due to myocardial ischemia or/and injury. The most common reason of ischemic cardiac disease is atherosclerosis influencing both vascular systems of coronary and brain. A forceful myocardial dysfunction may be expected in patients with generalized coronary vascular lesion especially after sympathetic activation (Melin and Fogelholm 1983; White et al. 1995) . As we did not perform coronary angiography to all of these patients with stroke, we could not make any comment on this suggestion. However the medical files of our patients revealed that 5 (4 ischemic and 1 hemorrhagic) of our study patients previously underwent coronary angiography and 4 of them had serious coronary lesions (three patients with lesion in 3 vessels, and one patient with lesion in 2 vessels). Notably, all patients with a coronary lesion had cTnT levels (0.56 ± 0.2 ng/ml) higher than cutoff level of 0.1 ng/m.
Earlier studies reported contradictory findings about the ST-T abnormalities observed after stroke. Melin and Fogelheim (1983) detected ST changes in 26.31% of patients and T changes in 28%. Rudehill et al. (1982) found that 10.3% of the patients had ST changes, and 31.77% had T changes. Several other studies reported ST changes at a percentage between 39.8% and 50%; T wave changes between 25-50% (Dimond and Grob 1977; Goldstein 1978; Brouwers et al. 1989; Grad et al. 1991) . The reason for different results may be due to differences in features of patient populations and observers' evaluation of ECG.
As a conclusion, cTnT is a specific and sensitive marker in detecting myocardial injury after stroke of both ischemic and hemorrhagic origines, compared to CK-MB. In addition, measurement of the serum levels of cTnT provides an useful aid in estimating the volume of stroke lesions and possibly the prognosis of the stroke in clinical practice. Similar studies with serial assessment and long-term follow-up data are warranted in larger populations.
